PARP14 can promote pancreatic cancer (PC) cell proliferation, anti-apoptosis, and GEM resistance, highlighting its potential role as a therapeutic target for PC (Yao et al., 2019). This evidence concerns the gene PARP14 and pancreatic neoplasm.